Announcements
- ONWARD® Medical Obtains Debt Financing with up to €52.5 Million Secured Loan from Runway Growth Capital LLC
- ONWARD® Medical Announces Participation in Stifel European Healthcare Summit
- ONWARD® Medical to Highlight Brain-Computer Interface at HLTH Europe Conference
- ONWARD® Medical Announces Results of Annual General Meeting of Shareholders
- ONWARD® Medical berichtet über das 1. Quartal 2024 und die bisherigen Höhepunkte des Jahres
- ONWARD® Medical fait le point sur le premier trimestre 2024 et sur les faits marquants de l’année écoulée
- ONWARD® Medical Reports Q1 2024 Update and Year-to-Date Highlights
- ONWARD® Medical organise une téléconférence pour partager les détails relatifs à son étude clinique Up-LIFT et à sa publication dans la revue Nature Medicine
- ONWARD® Medical veranstaltet Webcast zu Einzelheiten der Up-LIFT-Studie und der aktuellen Veröffentlichung in Nature Medicine
- Nature Medicine se réjouit de partager l’amélioration significative de la fonction de la main et du bras après une lésion de la moelle épinière grâce à la thérapie ONWARD® ARC-EX® Therapy
More ▼
Key statistics
As of last trade ONWARD Medical NV (63E:STU) traded at 4.93, -22.48% below its 52-week high of 6.36, set on Feb 13, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 4.93 |
---|---|
High | 4.93 |
Low | 4.93 |
Bid | 4.91 |
Offer | 5.18 |
Previous close | 5.00 |
Average volume | 111.11 |
---|---|
Shares outstanding | 34.63m |
Free float | 28.07m |
P/E (TTM) | -- |
Market cap | 177.30m EUR |
EPS (TTM) | -1.20 EUR |
Data delayed at least 15 minutes, as of Jul 03 2024.
More ▼